Skip to main content

HighTower Advisors, LLC

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 1462245 CHICAGO, IL

Position in LCTX

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$157,794
-$6,483 QoQ
Shares Held
99,870
+1.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LCTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

HighTower Advisors, LLC holds $268,759,923 across 111 Biotechnology names. LCTX ranks #67 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in LCTX

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $157,794 99,870
2025-12-31 $164,277 98,370
2025-09-30 $166,245 98,370
2025-06-30 $52,512 57,706
2025-03-31 $25,967 57,706
2024-12-31 $28,853 57,706
2024-09-30 $35,131 38,606
2024-06-30 $55,671 55,671
2024-03-31 $94,677 63,971
2023-12-31 $58,937 54,071
2023-09-30 $63,803 54,071
2023-06-30 $48,103 34,116
2023-03-31 $75,174 50,116
2022-12-31 $39,915 34,116
2022-09-30 $37,760 33,416
2022-06-30 $52,797 33,416
2022-03-31 $51,460 33,416
2021-12-31 $81,869 33,416
2021-09-30 $83,956 33,316
2021-06-30 $46,500 16,316
2021-03-31 $38,342 16,316
2020-12-31 $28,716 16,316